
---
title: '股价10年31倍，中药龙头比茅台多涨16倍！A股优质稀缺龙头30强来了，持续高增长股曝光'
categories: 
 - 金融
 - 证券时报网
 - 数据
headimg: 'https://data.stcn.com/djsj/202106/W020210622657525535606.jpeg'
author: 证券时报网
comments: false
date: Tue, 22 Jun 2021 18:14:00 GMT
thumbnail: 'https://data.stcn.com/djsj/202106/W020210622657525535606.jpeg'
---

<div>   
<p style="text-align: left;">稀缺资产股票牛股成群。</p><p style="text-align: left;">有着中药茅台之称的<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>，今日股价狂飙，收盘站上430元大关，上涨6.43%，创出历史新高，收盘市值逼近2600亿元。该股已经稳稳成为中药行业市值榜首位，排名第二的<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000538" code="000538">云南白药</a>市值为1425亿元。放在整个A股看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>市值排进了前50名大关，排在<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600104" code="600104">上汽集团</a>前面，位居第47位，后者市值2582亿元。</p><p style="text-align:center"><img data-ratio="1.2615384615384615" data-s="300,640" src="https://data.stcn.com/djsj/202106/W020210622657525535606.jpeg" data-type="jpeg" data-w="1170" data-imgqrcoded="1" width="500px" height="630.5555555555555px" style="width: 500px; height: 630.556px;" oldsrc="W020210622657525535606.jpeg" referrerpolicy="no-referrer"></p><p style="text-align: left;">往前回溯看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>股价已经连续7年上涨，近10年累计涨幅超过31倍，是A股市场最具盛名的价值标杆之一。分析人士指出，一线城市的房产、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600519" code="600519">贵州茅台</a>，还有<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>们，都属于稀缺资产，有望受益于本轮大通胀。</p><p style="text-align: left;"><strong>10年31倍，中药龙头比茅台多涨16倍</strong></p><p style="text-align: left;">近期一个新闻登上热搜，或许助推了<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>的股价。据中新经纬报道，昨日早上，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>体验馆北京银河SOHO门店还没有到9点，就已经排起了长队，等待购买<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>。据悉，590元一粒的<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>，在每人限购两粒的情况下，在开门10分钟后，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>便已售罄。另据中国基金报报道，淘宝和京东等各大线上药店，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>的价格早已没有官方规定590元/粒的价格了，线上药店的价格基本在900元/粒-1800元/粒之间，相比官方规定的价格基本翻倍。</p><p style="text-align: left;">一时间，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>的购买难度，一度被类比抢茅台。而就在A股市场上，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>的股价表现，甚至远超茅台。数据显示，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>近10年累计涨幅超过31倍，而后者涨幅仅为15倍左右。也就是说，在过去10年，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>涨幅是茅台的两倍多，比后者多涨了16倍多。从年线来看，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>已经连续7年股价上涨。</p><p style="text-align:center"><img data-ratio="0.4921223" src="https://data.stcn.com/djsj/202106/W020210622657526167745.png" data-type="png" data-w="1079" data-imgqrcoded="1" width="500px" height="246.06116774791474px" style="width: 500px; height: 246.061px;" oldsrc="W020210622657526167745.png" referrerpolicy="no-referrer"></p><p style="text-align: left;"><strong>A股优质稀缺龙头30强来了</strong></p><p style="text-align: left;">公开信息显示，公司独家生产的国家一级中药保护品种——<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>，被誉为“国宝神药”、传统制作技艺被列入国家非遗名录，并被列入国家一级中药保护品种，被评为中国中药名牌产品。</p><p style="text-align: left;">有分析人士指出，和茅台类似，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>是A股市场上比较稀缺的资产，具有较高的护城河，能够持续稳定经营，难以被颠覆，且具有较好的提价权。在大通胀背景下，有提价权的稀缺资产，其抵御通胀的能力更强，也易于被市场资金接受。</p><p style="text-align: left;">据此，数据宝从公司市值业绩规模、行业地位、公司治理水平等指标，兼顾行业平衡，筛选出A股稀缺资产30股作为资产组合。</p><p style="text-align: left;">从行业分布来看，榜单中包含了3只高端白酒龙头，以及两大啤酒龙头；医药行业则纳入了创新药产业链多只龙头，包括<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600276" code="600276">恒瑞医药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300759" code="300759">康龙化成</a>等，以及医疗保健龙头<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300760" code="300760">迈瑞医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300015" code="300015">爱尔眼科</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>等，还有两大医美龙头、两大中药龙头等；其他消费类股票还包括了免税龙头<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS601888" code="601888">中国中免</a>、调味品龙头<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603288" code="603288">海天味业</a>、粮油龙头<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300999" code="300999">金龙鱼</a>、水电龙头<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600900" code="600900">长江电力</a>等。</p><p style="text-align: left;"><strong>持续高增长股曝光</strong></p><p style="text-align: left;">市场表现方面，30强股票今年股价均创出了历史新高。不过，有的股票在年初新高后出现了一定调整，有的股票则继续上涨，包括<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600436" code="600436">片仔癀</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300347" code="300347">泰格医药</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300759" code="300759">康龙化成</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300896" code="300896">爱美客</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600132" code="600132">重庆啤酒</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600600" code="600600">青岛啤酒</a>等个股6月份则续创新高。</p><p style="text-align: left;">由于行业前景不同，部分个股估值差异也较大。其中，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000708" code="000708">中信特钢</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600025" code="600025">华能水电</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600900" code="600900">长江电力</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ000786" code="000786">北新建材</a>等个股今年预测市盈率均不足20倍。估值较高个股主要集中在医疗行业，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300896" code="300896">爱美客</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS688363" code="688363">华熙生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300015" code="300015">爱尔眼科</a>等个股预测市盈率均超过百倍。</p><p style="text-align: left;">高估值对应高增长。比如<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300896" code="300896">爱美客</a>今年、明年及2023年净利增速一致预期均超过40%，均值超过50%。其他个股方面，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS601888" code="601888">中国中免</a>三年净利增速一致预测均值接近51%榜单居首，<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ002791" code="002791">坚朗五金</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS600763" code="600763">通策医疗</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SZ300122" code="300122">智飞生物</a>、<a class="trsHotWords" style="color: #2f67d1;text-decoration: none;" target="_blank" href="http://info.stcn.com/dc/stock/?stockcode=SS603259" code="603259">药明康德</a>等个股均超过30%。</p><p style="text-align:center"><img data-ratio="1.5505155" src="https://data.stcn.com/djsj/202106/W020210622657527193995.png" data-type="png" data-w="485" data-imgqrcoded="1" width="500px" height="775.2577319587629px" style="width: 500px; height: 775.258px;" oldsrc="W020210622657527193995.png" referrerpolicy="no-referrer"></p><p style="text-align: left;">声明：数据宝所有资讯内容不构成投资建议，股市有风险，投资需谨慎。</p> 
  
</div>
            